MENU
HRMY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Harmony Biosciences Holdings (HRMY) Ownership - Who owns Harmony Biosciences Holdings?
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs... Show more
Profile
Industry
N/A
Address
630 West Germantown Pike
Phone
+1 484 539-9800
Employees
246
Web
https://www.harmonybiosciences.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.98B
P/E Ratio
13.57
Total Cash
506.95M
Projected Growth
N/A
Total Debt
175.68M
Revenue
744.85M
Risk (Beta)
0.93
Dividend Yield
N/A
Total Cash/Share
8.83
Total Debt/Equity
N/A
Revenue/Share
12.82 USD as % of share price
Fundamentals
HRMY
Capitalization
1.98B
P/E Ratio
13.57
Risk (Beta)
0.93
Dividend Yield
N/A
Total Cash
507M
Total Cash/Share
8.83
Total Debt
176M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
12.82%
Revenue
745M
ROE
N/A
Book Value
721M
P/B Ratio
2.83
Cash Flow
N/A
Earnings
2.67
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
3.67
Current Revenue Per Employee
689302.25
Dividends Per Share - Security
N/A
EBITDA
238M
Float
N/A
Float - Current
N/A
Gross Income Margin
82.68
Revenue To Assets
16.05
Shares Held By Institutions
3B
Shares Outstanding - Current
57.4M
Total Liabilities
335M
Total Volume MTD
N/A
Value
N/A
Gain YTD
0.262
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
630 West Germantown Pike
Phone
+1 484 539-9800
Employees
246
Web
https://www.harmonybiosciences.com